Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 3
1954 2
1955 2
1957 1
1958 2
1959 2
1960 5
1962 1
1963 5
1964 3
1965 3
1966 7
1967 5
1968 5
1969 5
1970 3
1971 5
1972 4
1973 2
1974 2
1975 3
1976 3
1977 1
1978 2
1979 3
1983 3
1986 1
1989 2
1990 1
1991 1
1999 1
2001 1
2003 2
2004 2
2005 6
2006 1
2007 2
2008 3
2009 3
2010 2
2013 3
2014 1
2015 2
2017 2
2018 1
2019 3
2020 6
2021 6
2022 12
2023 9
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

153 results

Results by year

Filters applied: . Clear all
Page 1
Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study.
Solomon JJ, Danoff SK, Woodhead FA, Hurwitz S, Maurer R, Glaspole I, Dellaripa PF, Gooptu B, Vassallo R, Cox PG, Flaherty KR, Adamali HI, Gibbons MA, Troy L, Forrest IA, Lasky JA, Spencer LG, Golden J, Scholand MB, Chaudhuri N, Perrella MA, Lynch DA, Chambers DC, Kolb M, Spino C, Raghu G, Goldberg HJ, Rosas IO; TRAIL1 Network Investigators. Solomon JJ, et al. Among authors: forrest ia. Lancet Respir Med. 2023 Jan;11(1):87-96. doi: 10.1016/S2213-2600(22)00260-0. Epub 2022 Sep 5. Lancet Respir Med. 2023. PMID: 36075242 Clinical Trial.
Target inhibition of galectin-3 by inhaled TD139 in patients with idiopathic pulmonary fibrosis.
Hirani N, MacKinnon AC, Nicol L, Ford P, Schambye H, Pedersen A, Nilsson UJ, Leffler H, Sethi T, Tantawi S, Gravelle L, Slack RJ, Mills R, Karmakar U, Humphries D, Zetterberg F, Keeling L, Paul L, Molyneaux PL, Li F, Funston W, Forrest IA, Simpson AJ, Gibbons MA, Maher TM. Hirani N, et al. Among authors: forrest ia. Eur Respir J. 2021 May 27;57(5):2002559. doi: 10.1183/13993003.02559-2020. Print 2021 May. Eur Respir J. 2021. PMID: 33214209 Free PMC article. Clinical Trial.
Population-Based Penetrance of Deleterious Clinical Variants.
Forrest IS, Chaudhary K, Vy HMT, Petrazzini BO, Bafna S, Jordan DM, Rocheleau G, Loos RJF, Nadkarni GN, Cho JH, Do R. Forrest IS, et al. JAMA. 2022 Jan 25;327(4):350-359. doi: 10.1001/jama.2021.23686. JAMA. 2022. PMID: 35076666 Free PMC article.
Fluorescent-labeled cannabinoids.
Forrest IS, Green DE, Rose SD, Skinner GC, Torres DM. Forrest IS, et al. Res Commun Chem Pathol Pharmacol. 1971 Nov;2(6):787-92. Res Commun Chem Pathol Pharmacol. 1971. PMID: 5155586 No abstract available.
Penetrance of Deleterious Clinical Variants-Reply.
Forrest IS, Nadkarni GN, Do R. Forrest IS, et al. JAMA. 2022 May 17;327(19):1927. doi: 10.1001/jama.2022.4634. JAMA. 2022. PMID: 35579644 Free PMC article. No abstract available.
Chlorpromazine retention.
Forrest IS, Forrest FM, Serra MT. Forrest IS, et al. Am J Psychiatry. 1969 Aug;126(2):271-2. doi: 10.1176/ajp.126.2.271. Am J Psychiatry. 1969. PMID: 5804819 No abstract available.
IPF: time for the (ciliary) beat generation?
Wiscombe S, Forrest IA, Simpson AJ. Wiscombe S, et al. Among authors: forrest ia. Thorax. 2013 Dec;68(12):1088-9. doi: 10.1136/thoraxjnl-2013-203928. Epub 2013 Sep 4. Thorax. 2013. PMID: 24005445 No abstract available.
153 results